NO307546B1 - Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav - Google Patents

Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav

Info

Publication number
NO307546B1
NO307546B1 NO952418A NO952418A NO307546B1 NO 307546 B1 NO307546 B1 NO 307546B1 NO 952418 A NO952418 A NO 952418A NO 952418 A NO952418 A NO 952418A NO 307546 B1 NO307546 B1 NO 307546B1
Authority
NO
Norway
Prior art keywords
ketorolac
pain
optically pure
pharmaceutical composition
composition containing
Prior art date
Application number
NO952418A
Other languages
English (en)
Norwegian (no)
Other versions
NO952418D0 (no
NO952418L (no
Inventor
Timothy J Barberich
Stephen L Matson
William J Wechter
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO952418D0 publication Critical patent/NO952418D0/no
Publication of NO952418L publication Critical patent/NO952418L/no
Publication of NO307546B1 publication Critical patent/NO307546B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO952418A 1992-12-17 1995-06-16 Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav NO307546B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99198192A 1992-12-17 1992-12-17
PCT/US1993/012299 WO1994013283A1 (fr) 1992-12-17 1993-12-17 Procedes et compositions antipyretiques et analgesiques contenant du r-cetrolac optiquement pur

Publications (3)

Publication Number Publication Date
NO952418D0 NO952418D0 (no) 1995-06-16
NO952418L NO952418L (no) 1995-08-03
NO307546B1 true NO307546B1 (no) 2000-04-25

Family

ID=25537797

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952418A NO307546B1 (no) 1992-12-17 1995-06-16 Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav

Country Status (14)

Country Link
US (1) US5382591A (fr)
EP (1) EP0674511B1 (fr)
JP (1) JP2957701B2 (fr)
KR (1) KR100264814B1 (fr)
AT (1) ATE150969T1 (fr)
AU (1) AU696620B2 (fr)
CA (1) CA2151724C (fr)
DE (1) DE69309492T2 (fr)
DK (1) DK0674511T3 (fr)
ES (1) ES2100046T3 (fr)
FI (1) FI952985A (fr)
GR (1) GR3023741T3 (fr)
NO (1) NO307546B1 (fr)
WO (1) WO1994013283A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
US5981592A (en) * 1995-03-13 1999-11-09 Loma Linda University Medical Center Method and composition for treating cystic fibrosis
US5955504A (en) * 1995-03-13 1999-09-21 Loma Linda University Medical Center Colorectal chemoprotective composition and method of preventing colorectal cancer
EP1642575B1 (fr) * 1997-03-10 2009-10-28 Loma Linda University Medical Center Utilisation de r-carprofen pour la prévention de la maladie d'alzheimer
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6576191B1 (en) * 1999-09-30 2003-06-10 Therox, Inc. Apparatus for blood oxygenation
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
CA2406383A1 (fr) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Agents de reduction de a.beta.42
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
US20030181426A1 (en) * 2002-02-11 2003-09-25 Eisenach James C. Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
EP1603548A4 (fr) * 2003-02-05 2007-10-10 Myriad Genetics Inc Composition et methode de traitement de troubles neurodegeneratifs
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
PL1654002T5 (pl) 2003-08-07 2014-06-30 Allergan Inc Kompozycje do dostarczania środków terapeutycznych do oczu
WO2006001877A2 (fr) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Composition pharmaceutique et methode de traitement de troubles neurodegeneratifs
CN1946906A (zh) * 2004-04-29 2007-04-11 吉斯通护岸系统股份有限公司 用于墙、护墙和类似物的饰面
CA2618985A1 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et methode de traitement de troubles neurodegeneratifs
WO2006020850A2 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et technique de traitement de troubles neurodegeneratifs
WO2006020852A2 (fr) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Composition pharmaceutique et technique de traitement de troubles neurodegeneratifs
CA2615063A1 (fr) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. Formes posologiques et preparations a charge medicamenteuse elevee
EP2046119A2 (fr) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Traitement de troubles psychiatriques
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
CN112094271B (zh) * 2019-06-18 2023-03-21 鲁南制药集团股份有限公司 一种酮咯酸晶型及其制备方法
CN110540542A (zh) * 2019-09-12 2019-12-06 南京海融制药有限公司 一种苯乙酸类化合物的钠盐、结晶形式及其制备方法
EP4110329A4 (fr) * 2020-02-24 2024-04-10 Yinuoke Medicine Science Technology Company Ltd. Compositions et méthodes pour le traitement d'un choc cytokinique et d'un syndrome de libération de cytokines
CN114276350B (zh) * 2020-09-28 2023-05-16 鲁南制药集团股份有限公司 一种酮咯酸与吩嗪共晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
KR880701287A (ko) * 1986-04-16 1988-07-26 원본미기재 광학적으로 활성인 1,2-디하이드로-3H-피롤로(1, 2a)피롤-1-카복실산 유도체의 제조방법
ES2086536T3 (es) * 1990-03-16 1996-07-01 Procter & Gamble Uso de ketorolaco para el tratamiento de la enfermedad periodontal.
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac

Also Published As

Publication number Publication date
AU696620B2 (en) 1998-09-17
ES2100046T3 (es) 1997-06-01
CA2151724C (fr) 2000-10-31
NO952418D0 (no) 1995-06-16
WO1994013283A1 (fr) 1994-06-23
CA2151724A1 (fr) 1994-06-23
KR950703951A (ko) 1995-11-17
FI952985A (fi) 1995-08-16
JP2957701B2 (ja) 1999-10-06
DK0674511T3 (da) 1997-04-21
JPH08505133A (ja) 1996-06-04
DE69309492T2 (de) 1997-07-10
US5382591A (en) 1995-01-17
KR100264814B1 (ko) 2000-09-01
EP0674511B1 (fr) 1997-04-02
GR3023741T3 (en) 1997-09-30
ATE150969T1 (de) 1997-04-15
NO952418L (no) 1995-08-03
EP0674511A1 (fr) 1995-10-04
DE69309492D1 (de) 1997-05-07
FI952985A0 (fi) 1995-06-16
AU5872194A (en) 1994-07-04

Similar Documents

Publication Publication Date Title
NO307546B1 (no) Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav
RU94042899A (ru) Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофен
EP0727994A4 (fr) Procedes et compositions antipyretiques et analgesiques contenant de l'acide etodolique r optiquement pur
NO960067L (no) Nytt farmasöytisk preparat
DK1137416T3 (da) Anvendelse af langkædede N-alkylderivater af deoxynojirimycin til fremstilling af et lægemiddel til behandling af glycolipidophobnings-sygdomme
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
FI973163A0 (fi) Pidätyskyvyttömyyden hoitaminen käyttämällä (S)-oksibutyniiniä ja (S)-desetyylioksibutyniiniä
EP1022025A3 (fr) Methodes et compositions pour le traitement des vomissements, de la nausee et d'autres troubles faisant appel a l'ondansetron optiquement pur R(+)
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
HUP9904360A2 (hu) Eljárás emesis és központi idegrendszeri rendellenességek kezelésére, optikailag tiszta (+)-norciszaprid alkalmazásával
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
DE69800859T2 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
SE9101341D0 (sv) New medicinal use
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
RU95113855A (ru) Способ консервативного лечения ожогов глаз
RU93008441A (ru) Способ длительной антистрессорной терапии у хирургических больных
YU15301A (sh) PRIMENA R (+)- alfa-(2,3-DIMETOKSIFENIL)-1-[2-(4-FLUOROFENIL) ETIL] -4-PIPERIDINMETANOLA ZA LECENJE POREMEĆAJA SPAVANJA

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2002